Stay updated on Losartan and Nivolumab in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Losartan and Nivolumab in Pancreatic Cancer Clinical Trial page.

Latest updates to the Losartan and Nivolumab in Pancreatic Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedA revision label was updated from v3.5.3 to v3.5.4. This indicates a minor update to the page's versioning or metadata rather than substantive content changes.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page’s revision/version label has been updated from v3.5.2 to v3.5.3, reflecting a release of the website interface rather than a modification to the clinical trial record.SummaryDifference0.0%

- Check36 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check65 days agoChange DetectedA new revision label v3.5.0 has been added and the previous revision v3.4.3 has been removed.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check100 days agoChange DetectedRevision: v3.4.2 was added, and the government funding notice along with Revision: v3.4.1 were removed.SummaryDifference0.3%

Stay in the know with updates to Losartan and Nivolumab in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Losartan and Nivolumab in Pancreatic Cancer Clinical Trial page.